Latest Breaking News On - Cdx illuccix - Page 1 : comparemela.com

FDA Approval Sought for Use of TLX007-CDx in PSMA PET Imaging of Prostate Cancer

The FDA has received a new drug application for the use of TLX007-CDx in the preparation of PSMA PET imaging of prostate cancer.

Canada
Australia
United-states
Australian
Mike-crosby
Christian-behrenbruch
Cdx-illuccix
Telix-illuccix
Australian-therapeutic-goods-administration
Health-canada
Telix-pharmaceuticals
Veterans-prostate-cancer-awareness

Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery

13.11.2023 - Regulatory News: Telix Pharmaceuticals Limited (ASX: TLX, Telix) and Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announced an expansion of the IRiS (Imaging and Robotics in Surgery) Alliance through a strategic €6 million . Seite 1

Australia
Canada
Australian
Cdx-illuccix
Mauna-kea-cellvizio
Dedicaid-gmb
Mauna-kea
Drug-administration
Telix-pharmaceuticals-limited
Health-canada
Robotics-in-surgery-alliance
Australian-therapeutic-goods-administration

Telix Pharmaceuticals Limited: Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery

Telix Pharmaceuticals Limited: Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-kingdom
Japan
Canada
United-states
Belgium
Australia
Melbourne
Victoria
Switzerland
Paris
France-general
France

Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery

MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea.

United-kingdom
Switzerland
Paris
France-general
France
Canada
United-states
Australia
Belgium
Japan
Melbourne
Victoria

Telix Pharmaceuticals Limited: First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients

Telix Pharmaceuticals Limited: First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Japan
Melbourne
Victoria
Australia
United-states
Switzerland
United-kingdom
China
Canada
Belgium
Dingwei
Fujian